Albumin-bound nanoparticle paclitaxel.
Gradishar
William J
WJ
Lynn Sage Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, 303 East Chicago Avenue, Chicago, IL 60611, USA.
D000068196:Albumin-Bound Paclitaxel; D000418:Albumins / Q000191:economics / Q000627:therapeutic use; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant / Q000191:economics / Q000639:trends; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D049329:Nanostructures; D036103:Nanotechnology; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000191:economics; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000191:economics; D017239:Paclitaxel / Q000191:economics / Q000627:therapeutic use*; D011092:Polyethylene Glycols / Q000191:economics / Q000627:therapeutic use; D011355:Prodrugs / Q000191:economics / Q000627:therapeutic use
D000068196:Albumin-Bound Paclitaxel; D000418:Albumins; D011355:Prodrugs; D003841:Deoxycytidine; C022131:cremophor; D011092:Polyethylene Glycols; D000069287:Capecitabine; D017239:Paclitaxel; D005472:Fluorouracil